Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Giovanni Caforio
Pharma
What are the noncompete considerations in Caforio's next move?
Noncompete agreements have threatened executive moves in biopharma in the past. Will that block Giovanni Caforio's plans?
Angus Liu
Jul 1, 2024 12:02pm
BMS paid Giovanni Caforio $19.7M in his final year as CEO
Mar 21, 2024 1:30pm
BMS has a plan to reinvigorate recent drug launches
Oct 26, 2023 11:45am
Securities filing details BMS' yearslong courtship of Mirati
Oct 24, 2023 11:41am
With Revlimid sales down, BMS slashes 2023 revenue projection
Jul 27, 2023 11:43am
BMS scouts for M&A deals amid multiple new launches: CEO
Apr 27, 2023 1:13pm
